Evidence map›Paper›PMID 29733106›Full record

Trial reportJournal of child psychology and psychiatry, and allied disciplines2018

How do stimulant treatments for ADHD work? Evidence for mediation by improved cognition.

Larry W Hawk, Whitney D Fosco, Craig R Colder, James G Waxmonsky, William E Pelham, Keri S Rosch

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of child psychology and psychiatry, and allied disciplines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Current Pharmacological Treatments for ADHD.Current topics in behavioral neurosciences · 2022
    Review
  19. Caffeine enhances sustained attention among adolescents.Experimental and clinical psychopharmacology · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Larry W HawkDepartments of Psychology, University at Buffalo, SUNY, Buffalo, NY, USA.
Whitney D FoscoDepartments of Psychology, University at Buffalo, SUNY, Buffalo, NY, USA.
Craig R ColderDepartments of Psychology, University at Buffalo, SUNY, Buffalo, NY, USA.
James G WaxmonskyDepartment of Psychiatry, Penn State College of Medicine, Hershey, PA, USA.
William E PelhamDepartment of Psychology, Florida International University, Miami, FL, USA.
Keri S RoschCenter for Neurodevelopmental and Imaging Research, Department of Neuropsychology, Kennedy Krieger Institute, Baltimore, MD, USA.

Funding

Inhibitory control and clinical response in ADHDR01MH069434 · NIMH · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI HAWK, LARRY W · 2005 to 2009
$1.8M
NIMH NIH HHS R01 MH069434
6 · The paper itself

Abstract

backgroundStimulant medications such as methylphenidate (MPH) are the frontline treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). Despite their well-documented efficacy, the mechanisms by which stimulants improve clinical outcomes are not clear. The current study evaluated whether MPH effects on classroom behavior were mediated by improved cognitive functioning.

methodsChildren with ADHD (n = 82; 9-12 years old) participated in a week-long summer research camp, consisting of cognitive testing, classroom periods, and recreational activities. After a baseline day, participants completed a 3-day randomized, double-blind, placebo-controlled trial of MPH (at doses approximating 0.3 and 0.6 mg/kg of immediate-release MPH dosed TID). Cognitive domains included inhibitory control (Stop Signal Task and prepulse inhibition of startle), attention (Continuous Performance Task and reaction time variability), and working memory (forward and backward spatial span). Clinical outcomes included math seatwork productivity and teacher-rated classroom behavior. A within-subjects path-analytic approach was used to test mediation. MPH-placebo and dose-response contrasts were used to evaluate drug effects.

resultsMethylphenidate improved seatwork productivity and teacher ratings (ds = 1.4 and 1.1) and all domains of cognition (ds = 0.3-1.1). Inhibitory control (Stop Signal Task, SST) and working memory backward uniquely mediated the effect of MPH (vs. placebo) on productivity. Only working memory backward mediated the impact of MPH on teacher-rated behavior. The dose-response (0.6 vs. 0.3 mg/kg) effects were more modest for clinical outcomes (ds = 0.4 and 0.2) and cognition (ds = 0-0.3); there was no evidence of cognitive mediation of the clinical dose-response effects.

conclusionsThese findings are novel in demonstrating that specific cognitive processes mediate clinical improvement with stimulant treatment for ADHD. They converge with work on ADHD theory, neurobiology, and treatment development in suggesting that inhibitory control and working memory may be mechanisms of stimulant treatment response in ADHD. More work is necessary to evaluate the degree to which these findings generalize to chronic treatment, a broader array of clinical outcomes, and nonstimulant treatments.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildChild BehaviorCognitionDose-Response Relationship, DrugDouble-Blind MethodFemaleHumansMaleMemory, Short-TermMethylphenidateCentral Nervous System StimulantsMethylphenidateAttention-Deficit/Hyperactivity Disordercognitionmediationmethylphenidate

Identifiers

PMID29733106
PMCPMC10043810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.